Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical OncologyAyse Ocak Duran, Halit Karaca, Mehmet Besiroglu, et al.
Tumori|September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncologyAhmet Bilici, Mevlude Inanc, Arife Ulas, et al.
Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 25, 2015
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, et al.
Hepato-Gastroenterology|November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experienceUmut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Japanese Journal of Clinical Oncology|January 25, 2024
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre studyOmer Fatih Olmez, Ahmet Bilici, Ozlem Er, et al.
BMC Cancer|April 2, 2020
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 studySuayib Yalcin, Faysal Dane, Berna Oksuzoglu, et al.
Hepato-Gastroenterology|November 21, 2012
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from TurkeyMesut Seker, Alper Sevinc, Ramazan Yildiz, et al.
Pageof 13